Ascendis Pharma A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ascendis Pharma A/S generated cash of -$467,361,000, which is more than the previous year. Cash used in financing activities reached the amount of $134,292,000 last year. Net change in cash is therefore -$52,603,000.
Cash Flow
| 2014 | -18.40M | -405K | 47.90M |
|---|---|---|---|
| 2015 | -43.46M | -1.03M | 105.74M |
| 2016 | -60.17M | -672K | 117.46M |
| 2017 | -95.09M | -941K | 124.72M |
| 2018 | -138.80M | -2.64M | 203.26M |
| 2019 | -175.93M | -5.15M | 493.59M |
| 2020 | -271.54M | -291.19M | 602.65M |
| 2021 | -417.64M | -110.57M | 351.38M |
| 2022 | -495.69M | 61.73M | 396.77M |
| 2023 | -467.36M | 286.47M | 134.29M |
ASND Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 444.76M | 446.26M | 584.51M | 598.10M | 277.86M | 195.35M | 180.32M | 119.64M | 50.16M | 19.43M |
Operating activities | ||||||||||
Net income | -481.44M | -583.19M | -383.57M | -418.95M | -218.01M | -130.09M | -123.89M | -68.50M | -32.92M | -9.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 18.91M | 17.95M | 15.39M | 9.44M | 6.68M | 880K | 734K | 677K | 558K | 504K |
Stock-based compensation expense | 66.66M | 64.18M | 66.83M | 53.17M | 37.48M | 0 | 9.70M | 7.32M | 1.71M | 1.27M |
| Deferred income tax benefit | 66.66M | 64.18M | 66.83M | 53.17M | 37.48M | 0 | 9.70M | 7.32M | 1.71M | 1.27M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -32.10M | -11.32M | -6.92M | -1.85M | -1.87M | 182K | 99K | 777K | 228K | 413K |
Inventories | -78.25M | -55.26M | -75.40M | -5.48M | -5.63M | 0 | -5.71M | 1.55M | -3.32M | -766K |
Accounts payable | 3.47M | 45.11M | 40.74M | 7.34M | 7.50M | 8.26M | 10.75M | 4.71M | 3.40M | 2.62M |
Cash generated by operating activities | -467.36M | -495.69M | -417.64M | -271.54M | -175.93M | -138.80M | -95.09M | -60.17M | -43.46M | -18.40M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -213.84M | -226.03M | -537.75M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.44M | -14.48M | -24.23M | -21.55M | -5.15M | -2.64M | -941K | -672K | -1.03M | -405K |
Acquisitions Net | 49.95K | 9.36M | -10.18M | 1.69M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 286.47M | 61.73M | -110.57M | -291.19M | -5.15M | -2.64M | -941K | -672K | -1.03M | -405K |
Financing activities | ||||||||||
Common Stock Issued | 10.07M | 0 | 367.88M | 638.79M | 480.25M | 216.38M | 133.10M | 125.96M | 114.13M | 47.90M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.81M | -105.30M | -21.60M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 125.81M | 496.92M | -6.42M | -4.77M | -4.03M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 134.29M | 396.77M | 351.38M | 602.65M | 493.59M | 203.26M | 124.72M | 117.46M | 105.74M | 47.90M |
Net Change In Cash | -52.60M | -1.5M | -138.25M | -13.58M | 320.24M | 82.51M | 15.02M | 60.68M | 69.48M | 30.73M |
Cash at end of period | 392.16M | 444.76M | 446.26M | 584.51M | 598.10M | 277.86M | 195.35M | 180.32M | 119.64M | 50.16M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |